z-logo
open-access-imgOpen Access
The impact of antinuclear antibodies induced by anti-tumour necrosis factor alpha (anti-TNF-α) agents on the long-term treatment outcomes in rheumatoid arthritis patients
Author(s) -
Daniela Oliveira,
Ana Martins,
F. R. Martins,
M. Rato,
F. Oliveira Pinheiro,
Diogo Fonsêca,
S. Garcia,
Bruno Miguel Fernandes,
Carlos Vaz,
Miguel Bernardes,
Lúcia Costa
Publication year - 2021
Publication title -
sbr 2021 congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2021.1746
Subject(s) - rheumatoid arthritis , tumor necrosis factor alpha , medicine , anti nuclear antibody , immunology , antibody , etanercept , necrosis , autoantibody

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom